Limitations of at-home biohacking tests and the potential of microbiome research

At-home biohacking tests are not considered reliable due to lack of regulation, validation, and FDA approval. They use different methodologies and detect only a subset of bacterial species, making them unsuitable for clinical use. However, microbiome research is a promising area, albeit complex and unique. While current technology limits our understanding, there is potential for microbiome markers to indicate risk profiles in the future, although true diagnostics may still be a long way off.